Literature DB >> 7573372

Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis.

V Nickeleit1, L Zagachin, K Nishikawa, J H Peters, R O Hynes, R B Colvin.   

Abstract

Crescents are a severe and stereotyped glomerular response to injury that occur in several forms of glomerulonephritis that progress to renal failure. The key pathogenetic step that leads to glomerular scarring in unknown, but fibronectin (FN), the clotting system, macrophages, and proliferating parietal epithelial cells are known to participate. This study was designed to determine whether FN is synthesized locally, and in what molecular isoform, and whether cytokines known to promote FN synthesis are present in the crescent. Rats immunized with bovine glomerular basement membrane develop cellular crescents by 14 days and fibrous crescents and glomerulosclerosis by 35 days. In situ hybridization was performed with oligonucleotides specific for sequences common to all FN isoforms (total FN) or sequences specific for the alternatively spliced segments (EIIIA, EIIIB, and V). Throughout the time period (14, 21, and 35 days) all crescents and glomerular tufts contained cells with strong ISH signals for total and V+ mRNA, with the strongest signals present in large cellular crescents at day 21. In contrast, EIIIA+ and EIIIB+ mRNAs showed maximal abundance within sclerosing crescents at 35 days. Protein deposition of EIIIA+, EIIIB+, and V+ FN isoforms was confirmed by immunofluorescence with segment-specific FN antibodies. Transforming growth factor-beta and interleukin-1 beta, both known to promote FN synthesis, were found in cellular crescents (days 14 and 21) and were still present, but greatly diminished, in the sclerotic phase (day 35). In summary, EIIIA-, EIIIB-, and V+ FN mRNA plasma isoforms predominate in cellular crescents, whereas in the fibrosing stage, mainly the oncofetal EIIIA+, EIIIB+, and V+ isoforms are synthesized and accumulate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573372      PMCID: PMC1871008     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS.

Authors:  P VASSALLI; R T MCCLUSKEY
Journal:  Am J Pathol       Date:  1964-10       Impact factor: 4.307

2.  Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation.

Authors:  E Odermatt; J W Tamkun; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  On the origin of species of fibronectin.

Authors:  J E Schwarzbauer; J I Paul; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

5.  Three different fibronectin mRNAs arise by alternative splicing within the coding region.

Authors:  J E Schwarzbauer; J W Tamkun; I R Lemischka; R O Hynes
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  The development of glomerular crescents in sheep.

Authors:  M P James; P B Herdson; J B Gavin
Journal:  Pathology       Date:  1981-07       Impact factor: 5.306

7.  The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  Am J Clin Pathol       Date:  1981-06       Impact factor: 2.493

8.  Human keratinocytes that have not terminally differentiated synthesize laminin and fibronectin but deposit only fibronectin in the pericellular matrix.

Authors:  R A Clark; L D Nielsen; S E Howell; J M Folkvord
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

9.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.

Authors:  G A Andres; L Accinni; S M Beiser; C L Christian; G A Cinotti; B F Erlanger; K C Hsu; B C Seegal
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

View more
  8 in total

1.  Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients.

Authors:  A J Coito; K Onodera; H Kato; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Tissue factor in crescentic glomerulonephritis.

Authors:  R T McCluskey
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

3.  Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

Authors:  A J Coito; L F Brown; J H Peters; J W Kupiec-Weglinski; L van de Water
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

4.  Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease.

Authors:  M Gharaee-Kermani; R Wiggins; F Wolber; M Goyal; S H Phan
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 5.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

6.  Healing corneas express embryonic fibronectin isoforms in the epithelium, subepithelial stroma, and endothelium.

Authors:  V Nickeleit; A H Kaufman; L Zagachin; J E Dutt; C S Foster; R B Colvin
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

7.  Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease.

Authors:  John H Peters; Tammy Greasby; Nancy Lane; Anthony Woolf
Journal:  Biomarkers       Date:  2009-06       Impact factor: 2.658

8.  Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.

Authors:  H Kosmehl; A Berndt; S Strassburger; L Borsi; P Rousselle; U Mandel; P Hyckel; L Zardi; D Katenkamp
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.